Lisa A. Hayes
Plus aucun poste en cours
Historique de carrière de Lisa A. Hayes
Anciens postes connus de Lisa A. Hayes
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Investor Relations Contact | 01/02/2021 | 01/02/2023 |
| Public Communications Contact | 01/02/2021 | 01/02/2023 | |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - | |
| PROQR THERAPEUTICS N.V. | Investor Relations Contact | 13/12/2018 | - |
| Public Communications Contact | 13/12/2018 | - | |
| CELGENE | Public Communications Contact | - | - |
Formation de Lisa A. Hayes
| St. Joseph's University | Masters Business Admin |
| New York University | Graduate Degree |
| Seton Hall University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Pays-Bas | 2 |
Opérationnelle
| Public Communications Contact | 4 |
| Investor Relations Contact | 3 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| CYTEIR THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Commercial Services |
- Bourse
- Insiders
- Lisa A. Hayes
- Expérience
